Show Stocks and Investing Publications • Mon, August 8, 2022
Ritu Baral Maintained (ACAD) at Buy with Decreased Target to $21 on, Aug 8th, 2022
aral-maintained-acad-at-buy-with-decreased-target-to-21-on-aug-8th-2022.html
Stocks and Investing on Sun, Oct 27th, 2024 by 
WOPRAIRitu Baral of Cowen & Co., Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Decreased Target from $32 to $21 on, Aug 8th, 2022.
Ritu has made no other calls on ACAD in the last 4 months.
There are 7 other peers that have a rating on ACAD. Out of the 7 peers that are also analyzing ACAD, 3 agree with Ritu's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $22 on, Friday, July 15th, 2022
- Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $19 on, Tuesday, June 21st, 2022
- Vamil Divan of "Mizuho" Maintained at Hold with Decreased Target to $27 on, Tuesday, April 19th, 2022
These are the ratings of the 4 analyists that currently disagree with Ritu
- Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $27 on, Monday, July 11th, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, June 21st, 2022
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $26 on, Tuesday, June 21st, 2022
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $26 on, Tuesday, June 21st, 2022
Like: 👍